title: Reply to the letter to the editor 'Can ovarian suppression with gonadotropin releasing hormone analogs (GnRHa) preserve fertility in cancer patients?' by Rodriguez-Wallberg et al.
authors.affiliation: Deapartment of Medical Oncology, U.O. Oncologia Medica 2, IRCCS AOU San Martino-IST, Genova.
authors.forename: M
authors.initials: M
authors.lastname: Lambertini
authors.affiliation: Fertility and Procreation Unit, Gynecologic Oncology Department, European Institute of Oncology, Milan, Italy.
authors.forename: F A
authors.initials: FA
authors.lastname: Peccatori
authors.affiliation: Cleveland Clinic Foundation, Taussig Cancer Institute, Cleveland, USA.
authors.forename: H C F
authors.initials: HC
authors.lastname: Moore
authors.affiliation: Deapartment of Medical Oncology, U.O. Sviluppo Terapie Innovative, IRCCS AOU San Martino-IST, Genova, Italy lucia.delmastro@hsanmartino.it.
authors.forename: L
authors.initials: L
authors.lastname: Del Mastro
mesh_terms: D005298:Fertility; D007987:Gonadotropin-Releasing Hormone; D006801:Humans; D009369:Neoplasms; D010053:Ovary
chemical_list: D007987:Gonadotropin-Releasing Hormone